The single most effective way to prevent human papillomavirus (HPV) is vaccination, ideally before any sexual contact. But prevention doesn’t stop there. A combination of vaccination, barrier protection, screening, and lifestyle choices can dramatically lower your risk of both infection and the cancers HPV can cause.
Vaccination: When and How Many Doses
The HPV vaccine protects against the strains responsible for most HPV-related cancers and genital warts. It works best when given before exposure to the virus, which is why the recommended starting age is 9 to 14 years old. At that age, only two doses are needed, spaced 6 to 12 months apart.
If you start the vaccine at age 15 or older, you need three doses: the first, then a second one to two months later, and a third at six months. This three-dose schedule applies to everyone who begins vaccination between ages 15 and 26, as well as anyone with a weakened immune system regardless of age.
For adults 27 through 45 who were never vaccinated (or never completed their series), the vaccine is still an option. The CDC recommends it on a shared decision-making basis, meaning you and your doctor weigh whether it’s likely to benefit you given your sexual history and risk factors. No HPV test or Pap smear is required beforehand to determine if vaccination makes sense. The vaccine prevents new infections but does not treat an existing one or speed up clearance of a strain you’ve already contracted.
How HPV Spreads
HPV is not transmitted through blood or bodily fluids. It passes through direct skin-to-skin contact, most commonly during sexual activity. That includes vaginal, anal, and oral sex, but also close skin-to-skin touching during sex that doesn’t involve penetration. This is why condoms help but can’t eliminate risk entirely: the virus can live on skin that a condom doesn’t cover.
Most sexually active people will encounter HPV at some point. The majority of infections are transient. Research published in BMJ Open found that cervicogenital HPV infections had a mean clearance time of about 87 days, with just over half of detected strains persisting from one study visit to the next. Oral HPV infections cleared even faster, averaging 46 days. Most people never know they were infected because the immune system handles it quietly. The concern is the small percentage of infections that persist for years and can eventually lead to cervical, anal, penile, vulvar, vaginal, or throat cancers, typically decades after the initial infection.
Condoms and Barrier Methods
Consistent condom use lowers the chances of getting HPV and developing HPV-related diseases like genital warts and cervical cancer. The protection isn’t complete because HPV can infect areas a condom doesn’t cover, such as the vulva, scrotum, and inner thighs. Still, condoms remain one of the most practical tools available. They reduce exposure to infected skin, and studies show they’re associated with lower rates of HPV-related conditions over time.
Dental dams offer a similar partial barrier during oral sex. For any barrier method, consistency matters more than occasional use. Using condoms some of the time provides meaningfully less protection than using them every time.
Fewer Partners, Lower Exposure
Each new sexual partner represents a new potential exposure to HPV strains your immune system hasn’t encountered. Limiting the number of partners you have over your lifetime is one of the simplest ways to reduce cumulative risk. This doesn’t mean monogamy is a guarantee of safety. Partners in long-term relationships tend to share HPV, and it’s not possible to determine which partner transmitted the original infection. Having HPV does not mean either partner has been unfaithful.
If you or your partner has tested positive for HPV, know that there’s no treatment for the virus itself, only for the conditions it can cause (like warts or precancerous cell changes). Condoms can still lower the chance of passing it to areas not yet infected, and vaccination can protect against strains neither of you has encountered.
Screening Catches What Prevention Misses
For people with a cervix, routine screening is a critical backstop. It doesn’t prevent HPV infection, but it catches the cell changes HPV can cause long before they become cancer. Current guidelines recommend:
- Ages 21 to 29: A Pap test every 3 years. HPV co-testing is not recommended in this age group.
- Ages 30 to 65: Primary HPV testing every 5 years (preferred), or a combined Pap and HPV test every 5 years. If HPV testing isn’t available, a Pap test alone every 3 years is acceptable.
Screening more often than every three years is not recommended for people at average risk. The point of these intervals is that cervical changes caused by HPV develop slowly, so more frequent testing leads to unnecessary procedures without improving outcomes.
There is currently no approved screening test for HPV-related cancers in men. No routine test exists for oral or anal HPV in the general population, which makes vaccination even more important for men, particularly since HPV causes the majority of oropharyngeal (throat) cancers and anal cancers.
Why Smoking Makes HPV More Dangerous
Smoking doesn’t just raise your cancer risk on its own. It specifically interferes with your body’s ability to fight off HPV. Components of cigarette smoke, including nicotine and its byproducts, suppress the local immune response in cervical tissue by reducing the number of immune cells stationed there. Smoking also increases the duration of high-risk HPV infections and decreases the likelihood that your body will clear them naturally.
Beyond immune suppression, tobacco compounds can accelerate the HPV life cycle, essentially giving the virus a head start in damaging cells. Quitting smoking is one of the most meaningful things you can do to help your immune system handle an HPV infection before it progresses.
Prevention for Men
HPV prevention conversations have historically centered on cervical cancer, but men face real risks too. Persistent HPV infections can develop into penile, anal, and oropharyngeal cancers, usually after several decades. Men who have sex with men face a particularly elevated risk of anal cancer.
The prevention toolkit for men is the same: vaccination (ideally before age 26, but available through 45), consistent condom use, and fewer partners. The CDC specifically notes that its vaccination recommendations for adults 27 through 45 apply equally to men who have sex with men, transgender individuals, and people with immunocompromising conditions. Since there’s no routine HPV screening available for men, vaccination is the primary line of defense.
Putting It All Together
No single strategy eliminates HPV risk. The most effective approach layers multiple tools: get vaccinated if you haven’t completed the series, use condoms consistently, keep up with cervical screening if it applies to you, avoid smoking, and have honest conversations with sexual partners. Most HPV infections resolve on their own, but the small fraction that don’t can cause serious disease. Prevention is about tilting the odds heavily in your favor across every layer you can control.